<DOC>
	<DOCNO>NCT02095899</DOCNO>
	<brief_summary>The purpose study test rufinamide effect chronic neuropathic pain patient post thoracotomy pain syndrome .</brief_summary>
	<brief_title>Effect Rufinamide Chronic Postthoracotomy Pain Syndrome</brief_title>
	<detailed_description>Patients chronic neuropathic pain thoracic surgery evaluate treated oxycodone . Patients stable analgesic regimen , reach good pain relief randomize receive Rufinamide ( Inovelon ) v . Placebo ad-on treatment oxycodone . Neurophysiological clinical data monitor .</detailed_description>
	<mesh_term>Peripheral Nerve Injuries</mesh_term>
	<criteria>Inclusion criterion , RunIn Phase : Age : 1875 year Weight : 50 100kg Height : 155 195cm Sufficient command German language Patient thoracotomy Pain duration 6 month . Diagnosis Neuropathic Pain ( DN4 questionnaire ) Average baseline mean last week pain intensity =5 NRS ( numerical rating scale ) Signed date informed consent Inclusion criterion , Treatment Phase : Stable analgesic regimen least 7 day prior randomisation Patients reach NRS = 3 ( numeric rating scale ) baseline individually dose adjust treatment ( oxycodone ) . Exclusion criterion : Contraindications class drug study , e.g . ( rufinamide , oxycodone ) know hypersensitivity allergy class drug Hypersensitivity triazole derivates antifungal drug include : fluconazole ( e.g . Diflucan速 ) , posaconazole ( Noxafil速 ) , itraconazole ( Sporanox速 ) , voriconazole ( Vfend速 ) Lactose intolerance , galactosemia galactokinase deficiency , glucosegalactose malabsorption Use topical analgesic , nerve block affect adjacent dermatome ( less 2 week prior therapy onset visit study period ) Women pregnant breast feeding ; intention become pregnant course study , lack safe contraception , define : female subject childbearing potential , use willing continue use medically reliable method contraception entire study duration , oral , injectable , implantable contraceptive , intrauterine contraceptive device , willing able use second ( additional ) consider sufficiently reliable investigator individual case . Female subject surgically sterilized/hysterectomized postmenopausal longer 2 year consider child bear potential Other clinically significant concomitant disease state ( e.g. , renal failure , hepatic dysfunction , severe cardiovascular disease , etc ) Creatinine clearance = 30 ml/min ( estimate serum creatinine use Cockcroft Gault formula ) exclude Known drug ( opiate ) alcohol abuse Contraindication use oxycodone Inability follow procedure study , e.g . due language problem , psychological disorder , dementia , etc . subject Participation another study investigational drug within 30 day precede present study Enrollment investigator , his/her family member , employee dependent person Known neurological disease peripheral manifestation include neuropathy associate disease diabetes Known sensory change medical condition ( e.g . infection affect investigation area , postherpetic neuralgia ) Epilepsy Abnormal electrocardiogram ( especially Familial Short QT syndrome ) Patient another pain condition great pain intensity Repeated thoracic surgery Pneumonectomy chest wall resection Bilateral thoracic surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Thoracic Surgical Procedures</keyword>
</DOC>